Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone

计划入组 173 人 · 首次发布于 2005 年 10 月 25 日

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

计划入组 126 人 · 首次发布于 2023 年 7 月 10 日

A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION

计划入组 673 人 · 首次发布于 2008 年 9 月 25 日

selegiline + PDE5 inhibitor (pulmonary arterial hypertension)

Tramadol + PDE5 Inhibitor (Aytu BioScience/Daewoong)

PDE5 inhibitors (Hangzhou Adamerck)

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

Mezzion Reports Positive In Vivo Results for PDE5 Inhibitor Udenafil in ADPKD, Plans Phase 2b Trial

Selexipag's Role in Pulmonary Arterial Hypertension: Timing Matters

AriBio and Arcera Forge $600 Million Partnership for Novel Alzheimer's Drug AR1001